Heather Morel, MBA
Advertisement
Articles by Heather Morel, MBA
REMS programs in acute and chronic pain management continue to evolve to reduce risk associated with pain medications.
REMS programs in acute and chronic pain management continue to evolve to reduce risk associated with pain medications.
What each stakeholder needs to know about REMS in today's fast-paced climate.
Advertisement
Latest Updated Articles
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: March 24th 2011 | Updated:
The Changing Landscape of REMS in Pain ManagementPublished: November 18th 2011 | Updated:
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: October 12th 2010 | Updated:
- REMS in Pain Management
Published: December 5th 2011 | Updated:
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: December 5th 2011 | Updated:
- REMS in Pain Management
Published: November 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
2
Therapeutic Cancer Vaccines: Are We There Yet?
3
Amivantamab Shows 45% Response Rate in Pretreated Head and Neck Cancer: OrigAMI-4 Findings
4
EV-303 Trial Shows Unprecedented Survival Benefit With Enfortumab Vedotin Plus Pembrolizumab in Cisplatin-Ineligible Bladder Cancer
5
